Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies
Authors
Keywords
-
Journal
PLoS One
Volume 11, Issue 5, Pages e0155823
Publisher
Public Library of Science (PLoS)
Online
2016-05-18
DOI
10.1371/journal.pone.0155823
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential effect of intranasally administrated kinin B1 and B2 receptor antagonists in Alzheimer’s disease mice
- (2016) Keren Asraf et al. BIOLOGICAL CHEMISTRY
- Quantitative and semi-quantitative measurements of axonal degeneration in tissue and primary neuron cultures
- (2016) Andrew Kneynsberg et al. JOURNAL OF NEUROSCIENCE METHODS
- The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
- (2015) Erdinç Dursun et al. JOURNAL OF NEUROIMMUNOLOGY
- First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease
- (2014) Christian Hölscher Alzheimers & Dementia
- Neuroprotective Effects of Angiotensin Receptor Blockers
- (2014) Sonia Villapol et al. AMERICAN JOURNAL OF HYPERTENSION
- Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis
- (2014) Deborah Doens et al. Journal of Neuroinflammation
- Microglia actions in Alzheimer’s disease
- (2013) Stefan Prokop et al. ACTA NEUROPATHOLOGICA
- Bradykinin decreases nitric oxide release from microglia via inhibition of cyclic adenosine monophosphate signaling
- (2013) Sarit Ben-Shmuel et al. PEPTIDES
- Ameliorative Effects of Telmisartan on the Inflammatory Response and Impaired Spatial Memory in a Rat Model of Alzheimer^|^#8217;s Disease Incorporating Additional Cerebrovascular Disease Factors
- (2012) Taro Shindo et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin–angiotensin system in the nigra
- (2012) Pablo Garrido-Gil et al. Brain Structure & Function
- Angiotensin II AT1receptor blockers as treatments for inflammatory brain disorders
- (2012) Juan M. Saavedra CLINICAL SCIENCE
- Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia
- (2012) Hongjun Fu et al. GLIA
- Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques
- (2012) Akihiro Noda et al. NUCLEAR MEDICINE AND BIOLOGY
- Inhibitory role of kinins on microglial nitric oxide and tumor necrosis factor-α production
- (2012) Ben-Shmuel Sarit et al. PEPTIDES
- Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats
- (2011) Koji Yamada et al. BRAIN RESEARCH
- Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases
- (2011) Joshua A. Smith et al. BRAIN RESEARCH BULLETIN
- Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics and neuronal synaptic damage in neurodegenerative diseases
- (2011) T Nakamura et al. CELL DEATH AND DIFFERENTIATION
- Angiotensin II AT1 Receptor Blockers Ameliorate Inflammatory Stress: A Beneficial Effect for the Treatment of Brain Disorders
- (2011) Juan M. Saavedra CELLULAR AND MOLECULAR NEUROBIOLOGY
- Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease
- (2011) Yi-Fei Dong et al. FASEB JOURNAL
- Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?
- (2011) Natalia N. Nalivaeva et al. JOURNAL OF NEUROCHEMISTRY
- Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System
- (2011) Sara L. Montgomery et al. Journal of Neuroimmune Pharmacology
- Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease
- (2011) James Scott Miners et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor κB and activator protein-1 activation
- (2010) Michio Miyoshi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Inflammation in neurodegenerative diseases
- (2010) Sandra Amor et al. IMMUNOLOGY
- Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity
- (2010) Izumi Maezawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Angiotensin II sustains brain inflammation in mice via TGF-β
- (2010) Tobias V. Lanz et al. JOURNAL OF CLINICAL INVESTIGATION
- The roles of TNF in brain dysfunction and disease
- (2010) Ian A. Clark et al. PHARMACOLOGY & THERAPEUTICS
- The role of NOS in the impairment of spatial memory and damaged neurons in rats injected with amyloid beta 25–35 into the temporal cortex
- (2010) Alfonso Diaz et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications
- (2010) Juan M. Saavedra et al. PSYCHONEUROENDOCRINOLOGY
- Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
- (2010) Lusine Danielyan et al. REJUVENATION RESEARCH
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension
- (2009) Kaycee M. Sink et al. ARCHIVES OF INTERNAL MEDICINE
- Crosstalk between peroxisome proliferator-activated receptor-γ and angiotensin II in renal tubular epithelial cells in IgA nephropathy
- (2009) Jing Xiao et al. CLINICAL IMMUNOLOGY
- Cognitive Deficit in Amyloid-β–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
- (2009) Kana Tsukuda et al. HYPERTENSION
- Angiotensin Receptor Blocker Prevented β-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling
- (2009) Shuko Takeda et al. HYPERTENSION
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
- (2009) Shyeilla V. Dhuria et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- PPARγ agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway
- (2009) Yuanyuan Ji et al. LABORATORY INVESTIGATION
- Telmisartan prevented cognitive decline partly due to PPAR-γ activation
- (2008) Masaki Mogi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential regulation of prostaglandin synthesis in neonatal rat microglia and astrocytes by somatostatin
- (2008) Julia Grinshpun et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Brain renin angiotensin in disease
- (2008) M. Ian Phillips et al. JOURNAL OF MOLECULAR MEDICINE-JMM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now